Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pantoprazole to prevent iron reaccumulation in hereditary hemochromatosis
2012-000603-32Phase 4Completed
- Sponsor
- Stichting Annadal
- Start
- Aug 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in hereditary hemochromatosis (HH) comparing Pantoprazole with Placebo (2 arms). Primary endpoint: Number of phlebotomies per year. Started Aug 2012; status: completed.
02
Drugs
pantoprazole
03
Conditions
hereditary hemochromatosis (HH)
Beyond the preview
Go deeper on 2012-000603-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-000603-32.